Plus Therapeutics positions CNSide for rapid growth by appointing seasoned leadership In a strategic move to strengthen its diagnostics division, Plus Therapeutics recently named Russell Bradley as President & General Manager of CNSide, alongside Dr. Marc Hedrick...

read more